2型糖尿病患者糖化血紅蛋白與甲狀腺激素水平的相關(guān)性研究
[Abstract]:Objective: to investigate the correlation between serum thyroid hormone and glycosylated hemoglobin (HbA1c) in type 2 diabetes mellitus. Methods: a total of 648 patients with type 2 diabetes mellitus were collected from January to December 2016, who were admitted to the Department of Endocrinology in our hospital. Gender, age, height, weight, liver and kidney function, blood glucose, blood lipid, glycosylated hemoglobin (Hb A1c), free triiodothyronine (FT3), free thyroxine (FT4), thyrotropin (TSH), were recorded. Past history includes severe heart, liver and kidney disease, thyroid disease and surgery, history of drug therapy, etc. Statistical methods included independent sample t-test, univariate ANOVA or non-parametric rank sum test to compare thyroid hormone levels among groups. Univariate correlation analysis (Pearson or Spearman) was used to analyze the relationship between glycosylated hemoglobin and other metabolic indexes and thyroid hormone levels. After adjusting for confounding factors, stepwise multiple linear regression was used. To investigate the correlation between glycosylated hemoglobin and thyroid hormone level. Results: 1. According to the status of blood glucose control of 648 patients with type 2 diabetes mellitus in China in 2007, HbA1c6.5% was classified as good control and HbA1c6.5-7.5% as general control. According to the blood sugar control condition, only 9.0% of the patients had good blood glucose control, 20.0% of the patients had moderate control of blood sugar, and most of the patients with diabetes had poor control of blood sugar. In the course of diabetes, the level of TC,TG,LDL-C was different among the three groups (P0.05), and with the increase of glycosylated hemoglobin, the level of TC,TG,LDL-C also increased in the course of diabetes. Gender, age, systolic blood pressure, diastolic blood pressure, BMI,HDL-C levels were not statistically significant (P0.05). There was no difference in positive rate of thyroid antibody and diabetic complications among the three groups (P0.05). The level of FT3 decreased with the course of diabetes, age and poor blood glucose control (P0.01). The level of FT3 in females was significantly lower than that in males. The level of FT4 decreased with the increase of age (P0.05), but it was significantly higher in the group with poor blood glucose control than that in the group with good blood glucose control. The level of TSH decreased in different groups, but there was no statistical significance in each group (P0.05). 4 the univariate correlation analysis of HbA1c and thyroid hormone levels showed that glycosylated hemoglobin (HbA1c) was associated with FT3,. The level of LogTSH was negatively correlated (r = -0.276, P 0.01). There was a positive correlation between the level of FT4 and the level of FT4 (P < 0.05), but there was a positive correlation with the level of FT4 (r = 0.105, P 0.01). In multiple linear regression, thyroid hormone FT3,FT4,LogTSH was used as dependent variable, after adjusting for sex, age, course of diabetes, systolic blood pressure, diastolic blood pressure, BMI,TG,HDL, creatinine, uric acid mixed factors. There was still a negative correlation between HbA1c and FT3 (t = -6.992, P < 0. 000). There was still a negative correlation between HbA1C and LogTSH (t = 2.231) and a positive correlation between HbA1c and FT4 (t = 2.546). Conclusion: the blood glucose control of type 2 diabetes patients in hospital is poor. In type 2 diabetes patients with normal thyroid function, HbA1c was negatively correlated with FT3,TSH and positively correlated with FT4.
【學(xué)位授予單位】:山東中醫(yī)藥大學(xué)
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2017
【分類號(hào)】:R587.1
【參考文獻(xiàn)】
相關(guān)期刊論文 前10條
1 許曉燕;李肅寧;;2型糖尿病合并甲狀腺疾病的臨床分析[J];寧夏醫(yī)學(xué)雜志;2016年09期
2 徐英英;高祥福;華燕吟;留菁菁;王陳芳;瞿中潔;冉婷;;血糖波動(dòng)對(duì)糖尿病大鼠理化指標(biāo)及甲狀腺功能的影響[J];浙江醫(yī)學(xué);2016年16期
3 郝鑫;施秉銀;趙新;;2型糖尿病住院患者甲狀腺功能分析[J];中國(guó)現(xiàn)代醫(yī)藥雜志;2015年01期
4 陶雅輝;畢菲菲;劉閣玲;王倩倩;;中老年2型糖尿病患者甲狀腺結(jié)節(jié)的患病情況分析[J];中國(guó)煤炭工業(yè)醫(yī)學(xué)雜志;2015年01期
5 王偉杰;趙麗;羅金玲;;糖尿病合并甲狀腺功能亢進(jìn)癥診治分析[J];中國(guó)實(shí)用內(nèi)科雜志;2012年S2期
6 ;甲狀腺結(jié)節(jié)和分化型甲狀腺癌診治指南[J];中國(guó)腫瘤臨床;2012年17期
7 任婷婷;吳藝捷;朱珠;林毅;徐艷紅;;住院糖尿病患者中甲狀腺結(jié)節(jié)的流行病學(xué)研究[J];現(xiàn)代生物醫(yī)學(xué)進(jìn)展;2012年15期
8 瞿衛(wèi);林艷麗;王自正;張瑞生;;HbA1c與DM2患者甲狀腺激素和膽紅素的關(guān)系[J];放射免疫學(xué)雜志;2010年05期
9 周飛華;徐海峰;周潤(rùn)鎖;孫濤;;糖尿病患者血清甲狀腺激素檢測(cè)的臨床意義分析[J];放射免疫學(xué)雜志;2008年04期
10 陳旭明;潘茹;;細(xì)胞因子與自身免疫性甲狀腺疾病的研究進(jìn)展[J];時(shí)珍國(guó)醫(yī)國(guó)藥;2007年05期
,本文編號(hào):2366297
本文鏈接:http://sikaile.net/yixuelunwen/nfm/2366297.html